Oral health strategies for healthy aging: A call to action

The FDA is as­sem­bling a new ad­vi­so­ry com­mit­tee to eval­u­ate po­ten­tial treat­ments for ge­net­ic meta­bol­ic dis­eases, the agency an­nounced Tues­day. Ge­net­ic meta­bol­ic dis­eases are typ­i­cal­ly

First Wave Bio­Phar­ma’s merg­er plans: The Flori­da biotech said it plans to merge with Im­muno­genX, an­oth­er gas­troin­testi­nal dis­eases com­pa­ny that is de­vel­op­ing an oral can­di­date